Abstract
Rheumatologists are increasingly asked to see patients with hepatitis C who exhibit a variety of clinical and serologic features that mimic systemic rheumatic disease. Treatment with interferons, now the standard of care, can precipitate a variety of inflammatory conditions, including sarcoidosis. We present a case of a 59-year-old former intravenous drug user who developed systemic sarcoidosis while receiving interferon alpha and ribavirin for the treatment of chronic hepatitis C. Because interferons are increasingly prescribed by specialists in a variety of disciplines, rheumatologists should be aware of their potential to induce sarcoidosis as well as various autoimmune diseases.
Original language | English (US) |
---|---|
Pages (from-to) | 241-248 |
Number of pages | 8 |
Journal | Journal of Clinical Rheumatology |
Volume | 12 |
Issue number | 5 |
DOIs | |
State | Published - Oct 1 2006 |
Externally published | Yes |
Keywords
- Autoimmunity
- Hepatitis C
- Interferon
- Sarcoidosis
ASJC Scopus subject areas
- Rheumatology